Results 41 to 50 of about 2,263,884 (199)
Effectiveness of airport screening at detecting travellers infected with novel coronavirus (2019-nCoV). [PDF]
, 2020 We evaluated effectiveness of thermal passenger screening for 2019-nCoV infection at airport exit and entry to inform public health decision-making.
Clifford, Sam +4 more
core +1 more source
The Emergence of Novel-Coronavirus and its Replication Cycle - An Overview
Journal of Pure and Applied Microbiology, 2020 Recently, a new viral-based infection has emerged as a respiratory disease caused by a novel (new) coronavirus that was first detected in Wuhan City, China.
Hafiz M.N. Iqbal +3 more
doaj +1 more source
Molecular Insights into the Contagious Nature of Pandemic Novel Coronavirus 2019-nCoV [PDF]
, 2020 This article stems from the author's observations that ORF10, a protein with no sequence and structural conservation, provides with a high number of potentially immunogenic, promiscuous epitopes.
Seema Mishra (8621172)
core +1 more source
Pattern of early human-to-human transmission of Wuhan 2019 novel coronavirus (2019-nCoV), December 2019 to January 2020 [PDF]
, 2020 Since December 2019, China has been experiencing a large outbreak of a novel coronavirus (2019-nCoV) which can cause respiratory disease and severe pneumonia.
Althaus, Christian L, Riou, Julien
core +1 more source
Containing 2019-nCoV (Wuhan) coronavirus [PDF]
Health Care Management Science, 2020 The novel coronavirus 2019-nCoV first appeared in December 2019 in Wuhan, China. While most of the initial cases were linked to the Huanan Seafood Wholesale Market, person-to-person transmission has been verified. Given that a vaccine cannot be developed and deployed for at least a year, preventing further transmission relies upon standard principles ...
openaire +3 more sources
Learning from the Past: Possible Urgent Prevention and Treatment Options for Severe Acute Respiratory Infections Caused by 2019-nCoV [PDF]
, 2020 With the current trajectory of the 2019-nCoV outbreak unknown, public health and medicinal measures will both be needed to contain spreading of the virus and to optimize patient outcomes.
Jared S. Morse (8279574) +3 more
core +1 more source
Pakistan Journal of Pharmaceutical Sciences, 2020 Emergence of novel coronavirus-2019 has become an international health concern. The objective of this review is to focus on 2019-nCoV emergence, prophylaxis and to predict the treatment approaches.
Muhammad Salman Rasool +3 more
doaj +1 more source
Chinese Medical Journal, 2020 . Background:. Medicines for the treatment of 2019-novel coronavirus (2019-nCoV) infections are urgently needed. However, drug screening using live 2019-nCoV requires high-level biosafety facilities, which imposes an obstacle for those institutions ...
Hua-Hao Fan +8 more
doaj +1 more source
Coronaviruses and COVID-19 – Complications and Lessons Learned for the Future
Journal of Pure and Applied Microbiology, 2020 Despite the earlier two Coronavirus outbreaks, this appearance of the third Coronavirus outbreak has brought several complications and now emerged as a human-health related pandemic issue.
Muhammad Bilal +4 more
doaj +1 more source
Heparins and 2019-nCoV infection: a narrative review. [PDF]
European review for medical and pharmacological sciences, 2021 Patients with 2019-nCoV infection have a high risk to develop venous thrombotic events. Several guidelines recommend the use of either unfractionated heparin or low molecular weight heparins in preventing thrombotic events in these patients. However, results from clinical studies, so far published, reached controversial conclusions on heparin efficacy ...
Doris BARCELLONA +6 more
openaire +2 more sources